Approval · Notice of Compliance 1788 · 1999
NU-FLUNISOLIDE: Notice of Compliance 1788
Issued October 21, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1788
- Date
- October 21, 1999
- Company
- Nu-Pharm IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Coritcosteroid for nasal use
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NU-FLUNISOLIDE | 02239288 | Cancelled Post Market |
Medicinal ingredients
- FLUNISOLIDE 0.25 MG per ML